Alkermes plc. insider trading
Every open-market purchase and sale by Alkermes plc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Alkermes plc.’s insiders pay?
From February 23, 2012 to August 3, 2026, 13 insiders reported 10 open-market purchases and 7 sales not made under a pre-set plan in Alkermes plc. Twelve months after each purchase was reported, the shares were +10.4% against the S&P 500 on average (median +6.5%), over 10 purchases with a full year of prices; 50% beat the index. After sales, the shares moved −4.0% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on May 1, 2012 into $29,729 by November 2, 2026, +7.8% a year. It held shares 54% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $31,573 (+8.3% a year), and held throughout $69,053 (+14.3%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Anstice David W | Director | 1 | +52.6% (1) | 100% | 1 | −60.8% (1) | December 13, 2018 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 0 | — | — | 2 | −2.3% (1) | May 29, 2026 |
| Snyderman Nancy Lynn Md | Director | 1 | +15.9% (1) | 100% | 1 | — | August 3, 2026 |
| Wysenski Nancy | Director | 2 | −39.0% (2) | 0% | 0 | — | February 25, 2020 |
| Alva Emily Peterson | Director | 1 | −13.4% (1) | 0% | 0 | — | August 24, 2021 |
| Bloom Floyd E | Director | 1 | +52.5% (1) | 100% | 0 | — | April 30, 2012 |
| Daglio David Angelo JR. | Director | 1 | −9.9% (1) | 0% | 0 | — | November 16, 2022 |
| Dixon Wendy L | Director | 1 | +31.2% (1) | 100% | 0 | — | March 13, 2014 |
| Elan Science Three Ltd | 10% owner | 0 | — | — | 1 | +21.4% (1) | March 14, 2012 |
| Henwood Geraldine | Director | 0 | — | — | 1 | +9.2% (1) | February 23, 2012 |
| Mckeon Brian P | Director | 1 | −2.8% (1) | 0% | 0 | — | August 4, 2021 |
| Pops Richard F | Director and CEO, Alkermes plc | 0 | — | — | 1 | +12.5% (1) | May 6, 2022 |
| Stejbach Mark | Chief Commercial Officer | 1 | +55.7% (1) | 100% | 0 | — | November 19, 2012 |
When several insiders traded Alkermes plc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Alkermes plc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged −21.9% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| August 31, 2021 | 2 buying | −31.1% | −21.9% | −13.0% |